Alzheimer’s disease is a progressive memory disorder that affects nearly one in three seniors and is on the rise, currently affecting 43 million people worldwide.
Behind the memory impairments, there is a perfect storm of destruction in the brain, stemming in part from accumulations of a protein called tau. Normally a stabilizing structure inside of neurons, tau can accumulate in long tangles that disrupt the ability of neurons to communicate with one another.
University of New Mexico researchers have developed a vaccine that could prevent the formation of the tau tangles and potentially prevent the cognitive decline typically seen in Alzheimer’s patients.
In a paper published last week in NPJ Vaccines, the team reported it had engineered a vaccine using virus-like particles (VLPs, for short) that eliminated the tau tangles in mice that had been bred to develop symptoms like those affecting human Alzheimer’s patients.
“We’re excited by these findings, because they seem to suggest that we can use the body’s own immune system to make antibodies against these tangles, and that these antibodies actually bind and clear these tau tangles,” said Nicole Maphis, a PhD candidate in UNM’s Biomedical Sciences Graduate Program.
Maphis, working in the lab of Kiran Bhaskar, PhD, an associate professor in UNM’s Department of Molecular Genetics & Microbiology, found that when the vaccine was given to mice, they developed antibodies that cleared the tau protein from their brains – and the response lasted for months.
Then, she tested the animals in a battery of maze-like tests. Mice receiving the vaccination performed remarkably better than those that hadn’t. MRI scans showed that the vaccinated animals had less brain shrinkage, suggesting that the vaccine prevented neurons from dying.
Maphis also found significantly fewer tangles in both the cortex and the hippocampus – areas in the brain that are important for learning and memory, and which are destroyed in Alzheimer’s.
“These results confirm that targeting tau tangles using a vaccine intervention could rescue memory impairments and prevent neurons from dying,” Maphis said.
The vaccine was created with help from UNM scientists David Peabody and Bryce Chackerian. The pair helped pioneer the use of VLPs to create vaccines targeting dengue virus, hepatitis B, human papillomavirus and amyloid beta protein (which is also present in the brains of Alzheimer’s patients).
VLPs are derived from viruses that have their genomes removed, leaving only their outer protein shell. Lacking a genome, they’re unable to reproduce, but the body’s immune system still recognizes them as foreign invaders and manufactures antibodies to neutralize the proteins attached to their surface. In this case, a portion of tau protein on the surface of the VLP triggers an immune response, leading to the elimination of the tau tangles.
Going forward, Bhaskar hopes to obtain funding to commercialize this vaccine in order to create an injection that could potentially be tested in human patients. However, moving a drug from bench to bedside can cost millions of dollars and take decades.
By partnering with AgilVax, Inc., a company formed to commercialize the VLP technology, and STC.UNM (UNM’s technology commercialization arm), Bhaskar hopes to receive funding from a federal Small Business Innovation Research grant to help move the research project forward.
Learn more: Memory Preserver
The Latest on: Alzheimer’s vaccine
[google_news title=”” keyword=”Alzheimer’s vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Alzheimer’s vaccine
- AstraZeneca withdraws COVID-19 vaccine, citing declining demandon May 9, 2024 at 3:26 am
The move ends a turbulent saga for AstraZeneca, which successfully developed a coronavirus shot but struggled to sell it amid competition and the emergence of rare but serious side effects.
- AstraZeneca pulls COVID-19 vaccine from global marketson May 8, 2024 at 11:55 am
British-Swedish drug maker AstaZeneca is pulling its Vaxzevria COVID-19 vaccine from sale globally. The company has admitted it could cause rare blood clots, but said the vaccine was pulled for ...
- Key COVID Vaccine Withdrawnon May 8, 2024 at 8:45 am
AstraZeneca cited a downturn in demand for its Vaxzevria vaccine, developed with the University of Oxford, on Wednesday, noting the vaccine will no longer be made or offered. It said it was ...
- Reuters Health News Summaryon May 7, 2024 at 10:01 pm
The lawsuit by Florida Attorney General Ashley Moody and the Catholic Medical Association (CMA), filed in federal court in Tampa, takes aim at a new rule published by the U.S. Department of Health and ...
- Vaccines Have Saved a Staggering 154 Million Lives in The Last 50 Yearson May 7, 2024 at 9:10 pm
Vaccination saves lives – an astounding 154 million of them since 1974 when the World Health Organization (WHO) launched its expanded global immunization programme, according to new research.
- Gene mutation may signal new genetic form of Alzheimer's diseaseon May 7, 2024 at 10:53 am
People who carry two copies of the gene mutation most strongly implicated in Alzheimer's disease are almost certain to develop brain changes related to the degenerative disorder, a new study says.
- US FDA panel to discuss Eli Lilly Alzheimer's drug on June 10on May 7, 2024 at 7:21 am
Eli Lilly said on Tuesday a panel of independent U.S. FDA advisers will discuss whether the agency should approve its Alzheimer's disease drug, donanemab, on June 10.
- Alzheimer's Newson May 5, 2024 at 5:00 pm
Their technique will help scientists differentiate synthetic peptides from toxic types found in Alzheimer's ... Nanomaterial That Mimics Proteins Could Be Basis for New Neurodegenerative Disease ...
- New café supporting dementia patients set for launchon April 29, 2024 at 4:58 pm
Selwood House Care Home in Charlton Down will launch a monthly community café which works to support people with dementia ...
- AstraZeneca admits its Covid vaccine can cause rare side effect in court documents for first timeon April 28, 2024 at 11:00 am
Pharmaceutical giant being sued in class action over claims its vaccine caused death and serious injury in dozens of cases ...
via Bing News